TD 1792

Known as: TD-1792, TD1792 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2012
02420082012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
TD-1792 is a new multivalent glycopeptide-cephalosporin antibiotic with potent activity against Gram-positive bacteria. The in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
TD-1792 is a first-in-class glycopeptide-cephalosporin heterodimer that exhibits bactericidal activity against Gram-positive… (More)
Is this relevant?
2012
2012
TD-1792 is a novel glycopeptide-cephalosporin heterodimer investigational antibiotic that displays potent bactericidal effects… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
TD-1792 is a multivalent glycopeptide-cephalosporin heterodimer antibiotic with potent activity against Gram-positive bacteria… (More)
  • table 1
  • table 1
Is this relevant?
2010
2010
TD-1792 is a glycopeptide-cephalosporin heterodimer antibiotic with activity against a broad spectrum of gram-positive pathogens… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2009
2009
The Interscience Conference on Antimicrobial Agents and Chemotherapy held in San Francisco included topics covering new… (More)
Is this relevant?
2008
2008
Further investigations towards novel glycopeptide/β-lactam heterodimers are reported. Employing a multivalent approach to drug… (More)
  • table 1
  • figure 1
Is this relevant?